Enigma Biomedical and McGill University sign research agreement for tau imaging agent MK-6240 Feb. 21, 2017
First-in-human trial demonstrates efficacy of 68Ga-BBN-RGD for prostate cancer diagnosis and staging Feb. 7, 2017
RSS